Comments on “Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study”

Ennio Giulio Favalli; Fabrizio Conti; Fabiola Atzeni; Carlo Selmi; Salvatore D'Angelo; Roberto Caporali; Florenzo Iannone

doi:10.1016/j.jaad.2018.07.052

Comments on “Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study”

Ennio Giulio Favalli, Fabrizio Conti, Fabiola Atzeni, Carlo Selmi, Salvatore D'Angelo, Roberto Caporali, Florenzo Iannone

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e119-e120
Journal	Journal of the American Academy of Dermatology
Volume	79
Issue number	6
DOIs	https://doi.org/10.1016/j.jaad.2018.07.052
Publication status	Published - Dec 1 2018

ASJC Scopus subject areas

Dermatology

Access to Document

10.1016/j.jaad.2018.07.052

Cite this

Favalli, E. G., Conti, F., Atzeni, F., Selmi, C., D'Angelo, S., Caporali, R., & Iannone, F. (2018). Comments on “Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study”. Journal of the American Academy of Dermatology, 79(6), e119-e120. https://doi.org/10.1016/j.jaad.2018.07.052

Comments on “Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials : A multicenter retrospective study”. / Favalli, Ennio Giulio; Conti, Fabrizio; Atzeni, Fabiola; Selmi, Carlo; D'Angelo, Salvatore; Caporali, Roberto; Iannone, Florenzo.

In: Journal of the American Academy of Dermatology, Vol. 79, No. 6, 01.12.2018, p. e119-e120.

Research output: Contribution to journal › Letter › peer-review

Favalli, EG, Conti, F, Atzeni, F, Selmi, C, D'Angelo, S, Caporali, R & Iannone, F 2018, 'Comments on “Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study”', Journal of the American Academy of Dermatology, vol. 79, no. 6, pp. e119-e120. https://doi.org/10.1016/j.jaad.2018.07.052

Favalli EG, Conti F, Atzeni F, Selmi C, D'Angelo S, Caporali R et al. Comments on “Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study”. Journal of the American Academy of Dermatology. 2018 Dec 1;79(6):e119-e120. https://doi.org/10.1016/j.jaad.2018.07.052

Favalli, Ennio Giulio ; Conti, Fabrizio ; Atzeni, Fabiola ; Selmi, Carlo ; D'Angelo, Salvatore ; Caporali, Roberto ; Iannone, Florenzo. / Comments on “Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials : A multicenter retrospective study”. In: Journal of the American Academy of Dermatology. 2018 ; Vol. 79, No. 6. pp. e119-e120.

@article{00c464581fcf42beba0bf178c223fa78,

title = "Comments on “Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study”",

author = "Favalli, {Ennio Giulio} and Fabrizio Conti and Fabiola Atzeni and Carlo Selmi and Salvatore D'Angelo and Roberto Caporali and Florenzo Iannone",

year = "2018",

month = dec,

day = "1",

doi = "10.1016/j.jaad.2018.07.052",

language = "English",

volume = "79",

pages = "e119--e120",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Mosby Inc.",

number = "6",

}

TY - JOUR

T1 - Comments on “Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials

T2 - A multicenter retrospective study”

AU - Favalli, Ennio Giulio

AU - Conti, Fabrizio

AU - Atzeni, Fabiola

AU - Selmi, Carlo

AU - D'Angelo, Salvatore

AU - Caporali, Roberto

AU - Iannone, Florenzo

PY - 2018/12/1

Y1 - 2018/12/1

UR - http://www.scopus.com/inward/record.url?scp=85056214124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056214124&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2018.07.052

DO - 10.1016/j.jaad.2018.07.052

M3 - Letter

C2 - 30096421

AN - SCOPUS:85056214124

VL - 79

SP - e119-e120

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 6

ER -

Comments on “Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study”

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this